Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00163267

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Follow-up Management of Peripheral Arterial Intervention With Clopidogrel MIRROR-Study

Sponsor: University Hospital Tuebingen

Interventions clopidogrel

Updated 7 times since 2017 Last updated: Aug 5, 2011 Started: Sep 30, 2005 Primary completion: Dec 31, 2009 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Peripheral Vascular Diseases, this trial is completed. The trial is conducted by University Hospital Tuebingen and has accumulated 7 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Tuebingen

Data source: University Hospital Tuebingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tübingen, Germany